Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions

被引：0
|
作者：
Kayo Fujita
Masayuki Kaneko
Mamoru Narukawa
机构：
[1] Kitasato University,Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences
来源：
Clinical Drug Investigation | 2017年 / 37卷
关键词：
Sitagliptin; Vildagliptin; Weighted Mean Difference; Saxagliptin; Japanese Subject;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：219 / 232
页数：13
相关论文
共 50 条
  • [31] Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis
    William Guo
    Sourish Rathi
    Jocellie Marquez
    Holly Smith
    Annet Kuruvilla
    Marcia G. Tonnesen
    Joann N. Salvemini
    Archives of Dermatological Research, 2023, 315 : 2207 - 2213
  • [32] Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis
    Zhang, Xiaodan
    Zhao, Qingyu
    JOURNAL OF HYPERTENSION, 2016, 34 (02) : 167 - 175
  • [33] Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure: A Network Meta-Analysis
    Guo, Wen-Qin
    Li, Lang
    Su, Qiang
    Dai, Wei-Ran
    Ye, Zi-Liang
    VALUE IN HEALTH, 2017, 20 (10) : 1427 - 1430
  • [34] Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis
    Guo, William
    Rathi, Sourish
    Marquez, Jocellie
    Smith, Holly
    Kuruvilla, Annet
    Tonnesen, Marcia G.
    Salvemini, Joann N.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (08) : 2207 - 2213
  • [35] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis
    Savarese, Gianluigi
    Perrone-Filardi, Pasquale
    D'Amore, Carmen
    Vitale, Cristiana
    Trimarco, Bruno
    Pani, Luca
    Rosano, Giuseppe M. C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 181 : 239 - 244
  • [36] Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease Risk: A Meta-analysis
    Radel, Joshua A.
    Pender, Danielle N.
    Shah, Sachin A.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (07) : 697 - 704
  • [37] A META-ANALYSIS OF EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 [DPP-4] INHIBITORS IN TYPE 2 DIABETES
    Park, H.
    Park, C.
    Kim, Y.
    Rascati, K. L.
    VALUE IN HEALTH, 2012, 15 (04) : A172 - A172
  • [38] A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis
    Farah, Daniela
    Leme, Graziella Malzoni
    Eliaschewitz, Freddy Goldberg
    Machado Fonseca, Marcelo Cunio
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 149 : 47 - 63
  • [39] Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis
    Goossen, K.
    Graeber, S.
    DIABETES OBESITY & METABOLISM, 2012, 14 (12): : 1061 - 1072
  • [40] Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Kidney Transplant Recipients with Post-transplant Diabetes Mellitus (PTDM)-a Systematic Review and Meta-Analysis
    Abdelaziz, Tarek Samy
    Ali, Ahmed Yamany
    Fatthy, Moataz
    CURRENT DIABETES REVIEWS, 2020, 16 (06) : 580 - 585
12345